Related Experiment Videos
Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells
Patrícia S Melo1, Giselle Z Justo, Mariângela B M de Azevedo
1Departamento de Bioquímica, Instituto de Biologia, Universidade Estadual de Campinas, CP 6109, CEP 13083-970 Campinas, São Paulo, Brazil.
Toxicology
|March 12, 2003
Summary
Violacein, a pigment from Chromobacterium violaceum, and its beta-cyclodextrin complexes effectively induce apoptosis in human leukemia cells (HL60). These compounds show potent anticancer effects by triggering DNA fragmentation and activating caspases.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Violacein, a pigment from Chromobacterium violaceum, exhibits known in vitro antitumor activities.
- Apoptosis induction is a key mechanism for anticancer agents targeting human tumor cell lines.
Purpose of the Study:
- To evaluate the efficacy of violacein/beta-cyclodextrin (beta-CD) systems in inducing cell death in the HL60 human promyelocytic leukemia cell line.
- To investigate the apoptotic pathways activated by violacein and its beta-CD complexes.
Main Methods:
- MTT tetrazolium reduction assay to determine IC(50) values.
- NBT reduction assay to assess cellular oxidative stress.
- Feulgen reaction and diphenylamine assay to quantify DNA fragmentation and apoptosis.
- Analysis of caspase involvement in the apoptotic process.
Main Results:
- IC(50) values for both violacein alone and its beta-CD complexes were below 1 microM.
- Violacein and its beta-CD complexes induced significant NBT reduction.
- Apoptosis was triggered in HL60 cells, with approximately 35% DNA fragmentation observed.
- Caspase activation was implicated in the execution phase of apoptosis.
Conclusions:
- Violacein and its beta-cyclodextrin complexes demonstrate significant cytotoxic effects against HL60 leukemia cells.
- These compounds effectively induce apoptosis, characterized by DNA fragmentation and caspase activation.
- Beta-cyclodextrin complexation enhances the potential of violacein as an anticancer agent.